PGD ONE FM™ – Preimplantation Diagnosis for Monogenic Diseases – most Frequent Mutations

PGD ONE FM™ – Preimplantation Diagnosis for Monogenic Diseases – most Frequent Mutations

PGD ONE FM™ is a test that detects the genetic defects (most frequent mutations) inherited by a child from their parents. DNA material from embryos is analysed prior to transfer to the uterus, that is, before the woman actually becomes pregnant.

The test can be carried out on material collected by biopsy in the 3rd (blastomere) or 5th/6th (trophectoderm cells) day of the embryo culture. Because of the risk of misdiagnosis caused by the pollution of sperm when using standard in vitro fertilization, the ICSI procedure is recommended. Any diagnosis of PGD ONE FM™ is treated individually and preceded by an examination of the material from the prospective parents. Under the procedure, a frozen embryos transfer (FET) is required.

We offer testing for all changes (mutations) in the nucleotide sequence such as:

  • single-nucleotide substitutions
  • deletions – up to 20 nucleotides
  • insertions – up to 20 nucleotides

 

INVICTA-Genetics
INVICTA-Genetics
INVICTA Genetic Laboratory has been performing genetic screening of embryos since 2005. Our team of world-class experts and scientists has been developing the innovative methods of preimplantation genetic diagnosis (PGD) for over 13 years.